180 related articles for article (PubMed ID: 15611260)
21. Interference of BCR-ABL1 kinase activity with antigen receptor signaling in B cell precursor leukemia cells.
Klein F; Feldhahn N; Müschen M
Cell Cycle; 2004 Jul; 3(7):858-60. PubMed ID: 15254401
[TBL] [Abstract][Full Text] [Related]
22. [A preliminary study on mechanisms for resistance of CML patient BM-derived bcr/abl+ and Flk1+CD31-CD34- stem cells to STI571 in vitro].
Song YP; Fang BJ; Wei XD; Zheng S
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1004-9. PubMed ID: 16403268
[TBL] [Abstract][Full Text] [Related]
23. Immunoglobulin genes in multiple myeloma: expressed and non-expressed repertoires, heavy and light chain pairings and somatic mutation patterns in a series of 101 cases.
Hadzidimitriou A; Stamatopoulos K; Belessi C; Lalayianni C; Stavroyianni N; Smilevska T; Hatzi K; Laoutaris N; Anagnostopoulos A; Kollia P; Fassas A
Haematologica; 2006 Jun; 91(6):781-7. PubMed ID: 16769580
[TBL] [Abstract][Full Text] [Related]
24. Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells.
Feldhahn N; Henke N; Melchior K; Duy C; Soh BN; Klein F; von Levetzow G; Giebel B; Li A; Hofmann WK; Jumaa H; Müschen M
J Exp Med; 2007 May; 204(5):1157-66. PubMed ID: 17485517
[TBL] [Abstract][Full Text] [Related]
25. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.
Majsterek I; Sliwinski T; Poplawski T; Pytel D; Kowalski M; Slupianek A; Skorski T; Blasiak J
Mutat Res; 2006 Jan; 603(1):74-82. PubMed ID: 16388976
[TBL] [Abstract][Full Text] [Related]
26. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
27. Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study.
Hofmann WK; de Vos S; Elashoff D; Gschaidmeier H; Hoelzer D; Koeffler HP; Ottmann OG
Lancet; 2002 Feb; 359(9305):481-6. PubMed ID: 11853794
[TBL] [Abstract][Full Text] [Related]
28. Chromatin remodeling at the Ig loci prior to V(D)J recombination.
Maës J; O'Neill LP; Cavelier P; Turner BM; Rougeon F; Goodhardt M
J Immunol; 2001 Jul; 167(2):866-74. PubMed ID: 11441093
[TBL] [Abstract][Full Text] [Related]
29. Plasma tyrosine kinase activity as a potential biomarker in BCR-ABL1-targeted therapy.
Yeh CH; Abdool A; Bruey JM
Cancer Biomark; 2010; 7(6):295-303. PubMed ID: 21694468
[TBL] [Abstract][Full Text] [Related]
30. Critical roles of the immunoglobulin intronic enhancers in maintaining the sequential rearrangement of IgH and Igk loci.
Inlay MA; Lin T; Gao HH; Xu Y
J Exp Med; 2006 Jul; 203(7):1721-32. PubMed ID: 16785310
[TBL] [Abstract][Full Text] [Related]
31. Contribution of immunoglobulin lambda light chain gene rearrangement analysis in the diagnosis of B-cell neoplasms.
Paterson AL; El-Daly H; Raso-Barnett L; Du MQ; Giger O; Soilleux E; Roberts T; Huang Y; Bibawi H; Matharu B; Bench A; Scott MA; Liu H
Br J Haematol; 2019 Apr; 185(2):261-265. PubMed ID: 30681735
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia.
Pfeifer H; Lange T; Wystub S; Wassmann B; Maier J; Binckebanck A; Giagounidis A; Stelljes M; Schmalzing M; Dührsen U; Wunderle L; Serve H; Brück P; Schmidt A; Hoelzer D; Ottmann OG
Leukemia; 2012 Jul; 26(7):1475-81. PubMed ID: 22230800
[TBL] [Abstract][Full Text] [Related]
33. A multifunctional element in the mouse Igκ locus that specifies repertoire and Ig loci subnuclear location.
Xiang Y; Zhou X; Hewitt SL; Skok JA; Garrard WT
J Immunol; 2011 May; 186(9):5356-66. PubMed ID: 21441452
[TBL] [Abstract][Full Text] [Related]
34. Invivoscribe BIOMED-2 primer mixes in B-cell immunoglobulin gene rearrangement studies: experience of a molecular diagnostics laboratory in a major tertiary care center.
Abbas F; Yazbek SN; Shammaa D; Hoteit R; Fermanian P; Mahfouz R
Genet Test Mol Biomarkers; 2014 Dec; 18(12):787-90. PubMed ID: 25299065
[TBL] [Abstract][Full Text] [Related]
35. Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571.
Gambacorti-Passerini C; Barni R; le Coutre P; Zucchetti M; Cabrita G; Cleris L; Rossi F; Gianazza E; Brueggen J; Cozens R; Pioltelli P; Pogliani E; Corneo G; Formelli F; D'Incalci M
J Natl Cancer Inst; 2000 Oct; 92(20):1641-50. PubMed ID: 11036109
[TBL] [Abstract][Full Text] [Related]
36. Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells.
Essafi A; Fernández de Mattos S; Hassen YA; Soeiro I; Mufti GJ; Thomas NS; Medema RH; Lam EW
Oncogene; 2005 Mar; 24(14):2317-29. PubMed ID: 15688014
[TBL] [Abstract][Full Text] [Related]
37. Minimal residual disease detection by next-generation sequencing of different immunoglobulin gene rearrangements in pediatric B-ALL.
Chen H; Gu M; Liang J; Song H; Zhang J; Xu W; Zhao F; Shen D; Shen H; Liao C; Tang Y; Xu X
Nat Commun; 2023 Nov; 14(1):7468. PubMed ID: 37978187
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of resistance to STI571 (Imatinib) in Philadelphia-chromosome positive acute lymphoblastic leukemia.
Hofmann WK; Komor M; Hoelzer D; Ottmann OG
Leuk Lymphoma; 2004 Apr; 45(4):655-60. PubMed ID: 15160936
[TBL] [Abstract][Full Text] [Related]
39. Evidence for Ig Light Chain Isotype Exclusion in Shark B Lymphocytes Suggests Ordered Mechanisms.
Iacoangeli A; Lui A; Haines A; Ohta Y; Flajnik M; Hsu E
J Immunol; 2017 Sep; 199(5):1875-1885. PubMed ID: 28760881
[TBL] [Abstract][Full Text] [Related]
40. RAG-mediated DNA double-strand breaks activate a cell type-specific checkpoint to inhibit pre-B cell receptor signals.
Bednarski JJ; Pandey R; Schulte E; White LS; Chen BR; Sandoval GJ; Kohyama M; Haldar M; Nickless A; Trott A; Cheng G; Murphy KM; Bassing CH; Payton JE; Sleckman BP
J Exp Med; 2016 Feb; 213(2):209-23. PubMed ID: 26834154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
